| A trial of gantenerumab or solanezumab in dominantly inherited Alzheimer’s disease S Salloway, M Farlow, E McDade, DB Clifford, G Wang, JJ Llibre-Guerra, ... Nature medicine 27 (7), 1187-1196, 2021 | 269 | 2021 |
| Temporal order of clinical and biomarker changes in familial frontotemporal dementia AM Staffaroni, M Quintana, B Wendelberger, HW Heuer, LL Russell, ... Nature medicine 28 (10), 2194-2206, 2022 | 59 | 2022 |
| An agent-based model of the Anopheles gambiae mosquito life cycle Y Zhou, SMN Arifin, J Gentile, SJ Kurtz, GJ Davis, BA Wendelberger Proceedings of the 2010 summer computer simulation conference, 201-208, 2010 | 31 | 2010 |
| Application of Bayesian methods to accelerate rare disease drug development: scopes and hurdles KM Kidwell, S Roychoudhury, B Wendelberger, J Scott, T Moroz, S Yin, ... Orphanet Journal of Rare Diseases 17 (1), 186, 2022 | 23 | 2022 |
| Epidemiology of out-of-hospital pediatric airway management in the 2019 national emergency medical services information system data set ER Hanlin, HK Chan, M Hansen, B Wendelberger, MI Shah, N Bosson, ... Resuscitation 173, 124-133, 2022 | 20 | 2022 |
| ICU‐free days as a more sensitive primary outcome for clinical trials in critically ill pediatric patients H Cho, B Wendelberger, M Gausche‐Hill, HE Wang, M Hansen, ... Journal of the American College of Emergency Physicians Open 2 (4), e12479, 2021 | 13 | 2021 |
| Evaluation of dose‐dependent treatment effects after mid‐trial dose escalation in biomarker, clinical, and cognitive outcomes for gantenerumab or solanezumab in dominantly … G Wang, Y Li, C Xiong, E McDade, DB Clifford, SL Mills, AM Santacruz, ... Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring 14 (1 …, 2022 | 8 | 2022 |
| Frontotemporal Dementia Prevention Initiative (FPI) Investigators. Temporal order of clinical and biomarker changes in familial frontotemporal dementia AM Staffaroni, M Quintana, B Wendelberger Nat Med 28 (10), 2194-2206, 2022 | 6 | 2022 |
| Adaptive multi-interventional trial platform to improve patient care for fibrotic interstitial lung diseases L Kawano-Dourado, T Kulkarni, CJ Ryerson, P Rivera-Ortega, BG Baldi, ... thorax, 2024 | 3 | 2024 |
| Futility in clinical trials B Wendelberger, RJ Lewis JAMA 330 (8), 764-765, 2023 | 3 | 2023 |
| Design of a novel clinical trial of prehospital pediatric airway management N Bosson, M Hansen, M Gausche-Hill, RJ Lewis, B Wendelberger, ... Clinical Trials 19 (1), 62-70, 2022 | 3 | 2022 |
| Critical factors in planning a pediatric prehospital airway trial M Hansen, N Bosson, M Gausche-Hill, MI Shah, JM VanBuren, ... Prehospital Emergency Care 26 (4), 476-483, 2022 | 2 | 2022 |
| July. An agent-based model of the Anopheles gambiae mosquito life cycle Y Zhou, SMN Arifin, J Gentile, SJ Kurtz, GJ Davis, BA Wendelberger SCSC2010: Proceedings of the Summer Computer Simulation Conference, 2010 | 2 | 2010 |
| Summer Simulation Multiconference Y Zhou, SMN Arifin, J Gentile, SJ Kurtz, GJ Davis, BA Wendelberger Ottawa, Ontario, Canada: Society for Computer Simulation International, 201-208, 2010 | 2 | 2010 |
| Mycophenolate and azathioprine efficacy in interstitial lung disease: a systematic review and meta-analysis F Lombardi, I Stewart, L Fabbri, W Adams, L Kawano-Dourado, ... BMJ Open Respiratory Research 11 (1), e002163, 2024 | 1 | 2024 |
| PET-CR as a potential surrogate endpoint in untreated DLBCL: meta-analysis and implications for clinical trial design K Broglio, L Kostakoglu, C Ward, F Mattiello, D Sahin, T Nielsen, ... Leukemia & Lymphoma 63 (12), 2816-2831, 2022 | 1 | 2022 |
| Disease progression models of familial frontotemporal lobar degeneration and the temporal ordering of biomarker changes in an international cohort AM Staffaroni, M Quintana, B Wendelberger, LL Russell, L Petrucelli, ... Alzheimer's & Dementia 17, e055353, 2021 | 1 | 2021 |
| The Epidemiology of Out-of-Hospital Pediatric Airway Management in the 2019 ESO Data Collaborative ER Hanlin, HK Chan, H Covert, M Hansen, B Wendelberger, MI Shah, ... Prehospital Emergency Care, 1-6, 2024 | | 2024 |
| Global platform trial design for tau (MAPT) mutation carriers AM Staffaroni, M Quintana, B Wendelberger, C Tartaglia, HW Heuer, ... Alzheimer's & Dementia 19, e078640, 2023 | | 2023 |
| Latent disease models estimate symptom onset in familial frontotemporal lobar degeneration and enable novel designs for early‐stage clinical trials: Developments in clinical … AM Staffaroni, M Quintana, B Wendelberger, HW Heuer, JC Rojas, ... Alzheimer's & Dementia 16, e045854, 2020 | | 2020 |
